TY - JOUR
T1 - Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire
AU - Cai, Tengda
AU - Tao, Yiwen
AU - Pan, Qi
AU - Yang, Luning
AU - Lin, Sen
AU - Chatterjee, Anal
AU - Meng, Weihua
AU - Song, Jingjing
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2025.
PY - 2025/8/5
Y1 - 2025/8/5
N2 - Introduction: Rheumatoid arthritis (RA) is the most prevalent autoimmune inflammatory joint disorder worldwide. We aimed to identify the genetic variants contributing to RA and investigate the potential influence of related diseases on RA risk. Methods: We performed genome-wide association studies (GWAS) on RA using the 2019 UK Biobank pain questionnaire. We conducted a primary GWAS (9,389 RA cases; 132,108 controls) and separate sex-stratified GWAS for females (4,832 cases; 75,184 controls) and males (4,557 cases; 56,924 controls). We incorporated 12 phenotypes from downstream analyses, such as genetic correlation analyses, transcriptome-wide association studies (TWAS), phenome-wide association studies (PheWAS), and Mendelian randomization (MR) studies to determine causal relationships with RA. Results: Two loci reached genome-wide significance in the primary GWAS. The top SNP, rs35139284 (p = 3.67 × 10−25) in the HLA-DRB1 gene on chromosome 6, exhibited a robust replication. Another locus, harboring the top SNP rs539837 (p = 6.26 × 10−9) near the LINC01680 gene on chromosome 1, also showed a significant association. In the female-specific GWAS, rs35139284 (p = 1.91 × 10−22) remained the top signal, whereas the male-specific GWAS revealed a suggestive significance at rs9267989 (p = 5.28 × 10−8) in TSBP1-AS1. TWAS and tissue specificity studies pointed to the spleen, lung, and small intestine as key tissues implicated in RA. PheWAS and MR analyses highlighted asthma and eosinophils associated with RA. Conclusion: Our findings confirmed an RA locus at chromosome 6 and highlighted associations between RA and a spectrum of immune-related and inflammatory phenotypes. Further analyses may provide greater insights into the genetic architecture of RA. (Table presented.)
AB - Introduction: Rheumatoid arthritis (RA) is the most prevalent autoimmune inflammatory joint disorder worldwide. We aimed to identify the genetic variants contributing to RA and investigate the potential influence of related diseases on RA risk. Methods: We performed genome-wide association studies (GWAS) on RA using the 2019 UK Biobank pain questionnaire. We conducted a primary GWAS (9,389 RA cases; 132,108 controls) and separate sex-stratified GWAS for females (4,832 cases; 75,184 controls) and males (4,557 cases; 56,924 controls). We incorporated 12 phenotypes from downstream analyses, such as genetic correlation analyses, transcriptome-wide association studies (TWAS), phenome-wide association studies (PheWAS), and Mendelian randomization (MR) studies to determine causal relationships with RA. Results: Two loci reached genome-wide significance in the primary GWAS. The top SNP, rs35139284 (p = 3.67 × 10−25) in the HLA-DRB1 gene on chromosome 6, exhibited a robust replication. Another locus, harboring the top SNP rs539837 (p = 6.26 × 10−9) near the LINC01680 gene on chromosome 1, also showed a significant association. In the female-specific GWAS, rs35139284 (p = 1.91 × 10−22) remained the top signal, whereas the male-specific GWAS revealed a suggestive significance at rs9267989 (p = 5.28 × 10−8) in TSBP1-AS1. TWAS and tissue specificity studies pointed to the spleen, lung, and small intestine as key tissues implicated in RA. PheWAS and MR analyses highlighted asthma and eosinophils associated with RA. Conclusion: Our findings confirmed an RA locus at chromosome 6 and highlighted associations between RA and a spectrum of immune-related and inflammatory phenotypes. Further analyses may provide greater insights into the genetic architecture of RA. (Table presented.)
KW - Genetics
KW - Genome-wide association study
KW - Mendelian randomization
KW - Rheumatoid arthritis
UR - https://www.scopus.com/pages/publications/105012633008
U2 - 10.1007/s10067-025-07590-x
DO - 10.1007/s10067-025-07590-x
M3 - Article
C2 - 40762897
AN - SCOPUS:105012633008
SN - 0770-3198
JO - Clinical Rheumatology
JF - Clinical Rheumatology
ER -